.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent advances in supramolecular pharmaceutical purification have introduced a sophisticated method for isolating high-value drugs. Specifically, researchers have engineered asymmetric ligands that assemble into interconverting palladium-based cages. These structures, known as PdL(BF) and PdL(NTf), respond to specific counter-anions to trigger structural changes. Consequently, this system enables a clean 'catch-and-release' mechanism for targeted pharmaceutical molecules.
Furthermore, the metal-organic cages possess distinct recognition profiles for different chemical guests. In addition, each cage configuration binds a unique subset of molecules with high selectivity. However, the structural interconversion remains reversible and quantitative under mild conditions. Therefore, by applying specific anions, the system isolates Darunavir from complex pharmaceutical mixtures. Finally, the team validated a closed-loop purification process with exceptional efficiency. Moreover, this strategy offers a broadly applicable solution for advanced molecular separations in manufacturing.
These cages allow for a reversible and selective separation process. By changing counter-anions, the cage structure shifts to either capture or release specific drug molecules like Darunavir.
This technology simplifies the purification of complex drugs. It provides a more efficient, closed-loop alternative to traditional separation methods, potentially lowering production costs and improving drug purity.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New palladium-based supramolecular cages enable the selective capture and release of Darunavir, offering a breakthrough for high-purity drug manufacturing....
6 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
